Skip to content

A cross-sectional study on rapid and automatic identification of asymptomatic myocardial infarction in the elderly based on artificial intelligence ECG diagnosis

A cross-sectional study on rapid and automatic identification of asymptomatic myocardial infarction in the elderly based on artificial intelligence ECG diagnosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056934
Enrollment
Unknown
Registered
2022-02-23
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asymptomatic myocardial infarction in the elderly

Interventions

Gold Standard:Diagnosis is confirmed by cardiac MRI.
Index test:Blood count, liver function, kidney function, blood glucose, glycosylated hemoglobin, uric acid, homocysteine, blood lipid profile, cardiac color ultrasound, conventional eighteen-lead ECG

Sponsors

Yu Yang
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patient's age is = 60 years old; 2. Clinically confirmed type 2 diabetes patients; 3. The classification and diagnostic criteria of diabetes refer to the 2020ADA diabetes medical diagnosis and treatment standards; 4. Patients with myocardial ischemia in combination with ECG.

Exclusion criteria

Exclusion criteria: 1. ECG showed atrial fibrillation, complete left bundle branch block, complete right bundle branch block and pacing ECG patients; 2. Chronic kidney disease (CKD); 3. Patients with end-stage renal disease (renal transplant patients, patients with eGFR<30 ml/min per 1.73m2 or receiving maintenance renal dialysis); 4. Patients with a clear history of myocardial infarction; 5. Patients with senile dementia or mental disorder; 6. The researcher thinks it is inappropriate to participate in this experiment; 7. According to the investigator's judgment, there are concomitant diseases that seriously endanger the patient's safety or affect the patient's completion of the study; 8. People who are known to be allergic to the contrast agent used in the test.

Design outcomes

Primary

MeasureTime frame
Conventional eighteen-lead ECG;Cardiovascular magnetic resonance;

Secondary

MeasureTime frame
Cardiac ultrasound;

Countries

China

Contacts

Public ContactYu Yang

Affiliated Hospital of Guangdong Medical University

851549090@qq.com+86 13828294242

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026